Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
74.78
+4.62 (6.58%)
At close: Jun 26, 2026, 4:00 PM EDT
78.44
+3.66 (4.89%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Disc Medicine Employees
Disc Medicine had 155 employees as of December 31, 2025. The number of employees increased by 71 or 84.52% compared to the previous year.
Employees
155
Change (1Y)
71
Growth (1Y)
84.52%
Revenue / Employee
n/a
Profits / Employee
-$1,568,851
Market Cap
2.86B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 155 | 71 | 84.52% |
| Dec 31, 2024 | 84 | 10 | 13.51% |
| Dec 31, 2023 | 74 | 28 | 60.87% |
| Dec 31, 2022 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 339 |
| Nurix Therapeutics | 317 |
| uniQure | 221 |
| Celldex Therapeutics | 198 |
| Pharvaris | 134 |
| MBX Biosciences | 63 |
IRON News
- 10 days ago - Disc Medicine Transcript: AGM 2026 - Transcripts
- 12 days ago - Disc Medicine price target raised to $85 from $80 at Morgan Stanley - TheFly
- 13 days ago - Disc Medicine Transcript: Study update - Transcripts
- 13 days ago - Disc Medicine Press release: Study update - Filings
- 13 days ago - Disc Medicine Slides: Study update - Filings
- 16 days ago - Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting - GlobeNewsWire
- 19 days ago - Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria - GlobeNewsWire
- 24 days ago - Disc Medicine Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts